Photostability of pitavastatin-A novel HMG-CoA reductase inhibitor

被引:21
|
作者
Grobelny, Pawel [2 ]
Viola, Giampietro [3 ]
Vedaldi, Daniela [4 ]
Dall'Acqua, Francesco [4 ]
Gliszczynska-Swiglo, Anna [5 ]
Mielcarek, Jadwiga [1 ]
机构
[1] Poznan Univ Med Sci, Dept Inorgan & Analyt Chem, PL-60780 Poznan, Poland
[2] Poznan Univ Med Sci, Dept Pharmaceut Technol, PL-60780 Poznan, Poland
[3] Univ Padua, Dept Pediat, Oncohematol Lab, I-35131 Padua, Italy
[4] Univ Padua, Dept Pharmaceut Sci, I-35128 Padua, Italy
[5] Poznan Univ Econ, Fac Commod Sci, PL-60967 Poznan, Poland
关键词
Statins; HMG-CoA reductase inhibitors; Pitavastatin; Photostability; Photodegradation; STATINS; STABILITY; WATER; ROSUVASTATIN; FORMULATION; SAFETY; PLASMA;
D O I
10.1016/j.jpba.2008.10.004
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The photostability of pitavastatin, an HMG-CoA reductase inhibitor used in the treatment of hypercholesterolemia, was investigated. The sample solution was exposed to UV-A radiation and the photodegradation process was monitored by means of spectro photometric method and HPLC-DAD. Pitavastatin was shown to be photolabile and its photodegradation reaction followed the first-order kinetics with the rate constant k = 3.54 x 10(-4) +/- 9.43 x 10(-6) s(-1). The chromatograms revealed the presence of four major photoproducts (PP-1-PP-4). The separated and isolated photolytic products were identified using a mass spectrometer coupled with a time of flight (TOF) analyzer. The main reaction observed during exposure to radiation of pitavastatin was photocyclisation leading to formation of four-ring photoproducts. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:597 / 601
页数:5
相关论文
共 50 条
  • [21] Novel role of HMG-CoA reductase inhibitor in keratinocyte proliferation and migration
    Attja, M. I.
    Murota, H.
    Katayama, I.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S57 - S57
  • [22] A new and efficient synthesis of the HMG-CoA reductase inhibitor pitavastatin (vol 90, pg 1069, 2007)
    Acemoglu, Murat
    Brodbeck, Andre
    Garcia, Angel
    Grimler, Dominique
    Hassel, Marc
    Riss, Bernhard
    Schreiber, Robert
    HELVETICA CHIMICA ACTA, 2007, 90 (07) : 1447 - 1447
  • [23] Cataract and HMG-CoA reductase inhibitor: a case report
    Bousquet, E
    Amar, J
    Salvador, M
    Chamontin, B
    THERAPIE, 1998, 53 (05): : 505 - 507
  • [24] THE PHARMACOLOGY OF FLUVASTATIN, A NEW HMG-COA REDUCTASE INHIBITOR
    GARNETT, WR
    CLINICAL CARDIOLOGY, 1994, 17 (12) : 3 - 10
  • [25] EFFICACY OF THE SYNTHETIC HMG-COA REDUCTASE INHIBITOR FLUVASTATIN
    KEILSON, L
    DUJOVNE, C
    HUNNINGHAKE, D
    INSULL, W
    KNOPP, R
    MCKENNEY, J
    STEIN, E
    TROENDLE, A
    ARTERIOSCLEROSIS, 1990, 10 (05): : A856 - A856
  • [26] HMG-COA REDUCTASE INHIBITOR THERAPY AND PERIPHERAL NEUROPATHY
    JACOBS, MB
    ANNALS OF INTERNAL MEDICINE, 1994, 120 (11) : 970 - 970
  • [28] Design of Tripeptides as a Competitive Inhibitor for HMG-CoA Reductase
    Valeriy V. Pak
    Dae Yong Kwon
    Olim K. Khojimatov
    Aleksandr V. Pak
    Shomansur Sh. Sagdullaev
    International Journal of Peptide Research and Therapeutics, 2021, 27 : 1923 - 1931
  • [29] Newer HMG-CoA reductase inhibitor (statin) therapies
    Brinton, EA
    CLINICAL CARDIOLOGY, 2001, 24 (07) : II10 - II13
  • [30] Photochemical activity of glenvastatin, a HMG-CoA reductase inhibitor
    Sobotta, L.
    Kachlicki, P.
    Marczak, L.
    Kryjewski, M.
    Mielcarek, J.
    JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY, 2011, 224 (01) : 1 - 7